Accelerating initiation of antiretroviral therapy

The Lancet HIV

Volumn 3, Issue 11, 2016, Pages e504-e505

  Ford, Nathan ^a   Nsanzimana, Sabin ^b,c,d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b RWANDA BIOMEDICAL CENTER   (Rwanda)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DECISION MAKING; FOLLOW UP; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; NOTE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS;

EID: 84994193793     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(16)30152-7     Document Type: Note

References (14)

1. 1 Harries, AD, Nyangulu, DS, Hargreaves, NJ, Kaluwa, O, Salaniponi, FM, Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 358 (2001), 410–414.
2. 2 Fox, RC, Goemaere, E, They call it “patient selection” in Khayelitsha: the experience of Medecins Sans Frontieres-South Africa in enrolling patients to receive antiretroviral treatment for HIV/AIDS. Camb Q Healthc Ethics 15 (2006), 302–312.
3. 3 Siedner, MJ, Lankowski, A, Haberer, JE, et al. Rethinking the “pre” in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One, 7, 2012, e39894.
4. 4 Mugglin, C, Estill, J, Wandeler, G, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 17 (2012), 1509–1520.
5. 5 Hoffmann, CJ, Lewis, JJ, Dowdy, DW, et al. Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model. J Acquir Immune Defic Syndr 63 (2013), 105–111.
6. 6 WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2nd edn., 2016, World Health Organization, Geneva http://www.who.int/hiv/pub/arv/arv-2016/en/ (accessed Aug 22, 2016).
7. 7 Amanyire, G, Semitala, FC, Namusobya, J, et al. Streamlining initiation of antiretroviral therapy in Africa: a stepped-wedged cluster-randomised trial. Lancet HIV, 2016 published online Aug 26. http://dx.doi.org/10.1016/S2352-3018(16)30090-X.
8. 8 Rosen, S, Maskew, M, Fox, MP, et al. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: the RapIT randomized controlled trial. PLoS Med, 13, 2016, e1002015.
9. 9 Chan, AK, Kanike, E, Bedell, R, et al. Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother-to-child transmission services at antenatal care in Zomba District, Malawi. J Int AIDS Soc, 19, 2016, 20672.
10. 10 Katirayi, L, Namadingo, H, Phiri, M, et al. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study. J Int AIDS Soc, 19, 2016, 20919.
11. 11 Carrieri, MP, Raffi, F, Lewden, C, et al. Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antivir Ther 8 (2003), 585–594.
12. 12 Ford, N, Darder, M, Spelman, T, Maclean, E, Mills, E, Boulle, A, Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort. PLoS One, 5, 2010, e10460.
13. 13 Bock, P, Anelet, J, Alliance, N, et al. Baseline CD4 count and adherence to antiretroviral therapy: a systematic review and meta-analysis. J Acquir Immune Defic Syndr, 2016, 10.1097/QAI.0000000000001092 published online June 16.
14. 14 Labhardt, ND, Ringera, I, Lejone, TI, et al. Same day ART initiation versus clinic-based pre-ART assessment and counselling for individuals newly tested HIV-positive during community-based HIV testing in rural Lesotho - a randomized controlled trial (CASCADE trial). BMC Public Health, 16, 2016, 329.